NewGenIvf (NIVF) Equity Ratio (2022 - 2025)

NewGenIvf (NIVF) has 4 years of Equity Ratio data on file, last reported at 0.81 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.81, up 377.68% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.81 (up 377.68% YoY), and the FY2025 annual result was 0.81, up 377.68% from the prior year.
• Equity Ratio declined to 0.81 in Q4 2025 per NIVF's latest filing, from 0.83 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.83 in Q3 2025 and troughed at 0.29 in Q4 2024.
• A 4-year average of 0.46 and a median of 0.67 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio soared 1986.98% in 2023, then plunged 140.52% in 2024.
• A 4-year view of Equity Ratio shows it stood at 0.03 in 2022, then soared by 1986.98% to 0.72 in 2023, then sank by 140.52% to 0.29 in 2024, then jumped by 377.68% to 0.81 in 2025.
• Business Quant data shows NIVF's Equity Ratio at 0.81 in Q4 2025, 0.83 in Q3 2025, and 0.63 in Q2 2025.